• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • AI SuperconnectorNEW
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • AI SuperconnectorNEW
  • Settings
  • RSS Feeds
PublishGo to AppAI Superconnector
    Quantisnow Logo

    © 2025 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI superconnector for talent & startupsNEW
    Legal
    Terms of usePrivacy policyCookie policy

    Xenia Hotels & Resorts Announces the Appointment of Terrence Moorehead to its Board of Directors

    5/26/21 6:30:00 AM ET
    $XHR
    $NATR
    Hotels/Resorts
    Consumer Discretionary
    Biotechnology: Pharmaceutical Preparations
    Health Care
    Get the next $XHR alert in real time by email

    ORLANDO, Fla., May 26, 2021 /PRNewswire/ -- Xenia Hotels & Resorts, Inc. (NYSE:XHR) ("Xenia" or the "Company") today announced the appointment of Mr. Terrence Moorehead to its Board of Directors, effective May 25, 2021.  Mr. Moorehead was also appointed as a member of the Audit Committee effective May 25, 2021. With the appointment, the Company's Board of Directors increased to nine members, eight of whom are independent, including Mr. Moorehead. 

    "On behalf of the Board of Directors and the management team, we are pleased to welcome Terrence to our Board," commented Marcel Verbaas, Chairman and Chief Executive Officer of Xenia.  "Terrence brings a fresh and diverse perspective to the Board, and we look forward to his contributions that will further enhance our leadership. His expertise in high-end consumer products and behaviors as well as his experience in and focus on health and wellness are valuable attributes that are directly relevant to the upper upscale and luxury lodging segments. Additionally, his strategic insights that have been honed by executive leadership roles throughout the world will be of significant value."

    Mr. Moorehead currently serves as President, Chief Executive Officer, and a director on the board of Nature's Sunshine Products, Inc (NASDAQ:NATR) ("Nature's Sunshine"), a leading natural health and wellness company.  Prior to joining Nature's Sunshine in 2018, Mr. Moorehead was Chief Executive Officer at Carlisle Etcetera LLC from 2015 through 2018, and at Dana Beauty, Inc. from 2013 to 2015.  From 1991 to 2013 he served in various capacities at Avon Products, Inc., including, among other positions, as VP, Strategy and Digital, North America, President and Chairman of Avon Japan, President of Avon Canada, and General Manager of Avon Italy. 

    Mr. Moorehead received his Master of Business Administration from Columbia University and a Bachelor of Arts in Economics from Boston College.

    "I am excited to be joining Xenia's Board of Directors and to have the opportunity to work with such an outstanding team of professionals. The Company's high-quality properties, differentiated portfolio, and top-notch management team are a powerful combination and I look forward to working with the team to deliver increased shareholder value," commented Mr. Moorehead.

    About Xenia Hotels & Resorts, Inc.

    Xenia Hotels & Resorts, Inc. is a self-advised and self-administered REIT that invests in uniquely positioned luxury and upper upscale hotels and resorts with a focus on the top 25 U.S. lodging markets as well as key leisure destinations in the United States. The Company owns 35 hotels and resorts comprising 10,011 rooms across 15 states. Xenia's hotels are in the luxury and upper upscale segments, and are operated and/or licensed by industry leaders such as Marriott, Hyatt, Kimpton, Fairmont, Loews, Hilton, and The Kessler Collection. For more information on Xenia's business, refer to the Company website at www.xeniareit.com.

    This press release contains statements as to the Company's beliefs and expectations of the outcome of future events that are forward-looking statements as defined in the Private Securities Litigation Reform Act of 1995 and within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended. You can identify these statements by the fact that they do not relate strictly to historical or current facts. These forward-looking statements are subject to risks and uncertainties that could cause actual results to differ materially from the statements made. These risks and uncertainties include, but are not limited to, the effects of the COVID-19 pandemic, including on the demand for travel, transient and group business (including, but not limited to, government-imposed travel or meeting restrictions), and levels of consumer confidence in the safety of travel as a result of the pandemic; the length of the COVID-19 pandemic and severity of such pandemic in the United States; the pace of economic recovery and the recovering of consumer confidence following the COVID-19 pandemic; our ability to implement cost-containment strategies; the adverse effects of the COVID-19 pandemic on our business or the market price of our common stock; and our ability to service, restructure or refinance our debt; our ability to be in compliance with our debt covenants; our ability to access capital on acceptable terms or at all and uncertainty in both the debt and equity capital markets; and the outcome of legal proceedings or other disputes. Other factors that could cause results to differ are described in the filings made from time to time by the Company with the U.S. Securities and Exchange Commission and include the risk factors and other risks and uncertainties described in the Company's Annual Report on Form 10-K for the year ended December 31, 2020, its Quarterly Report on Form 10-Q for the quarter ended March 31, 2021 and its Current Reports on Form 8-K. Except as required by law, the Company does not undertake, and hereby disclaims, any obligation to release publicly any revisions to forward-looking statements made by it to reflect events or circumstances occurring after the date hereof or the occurrence of unanticipated events.

    Cision View original content:http://www.prnewswire.com/news-releases/xenia-hotels--resorts-announces-the-appointment-of-terrence-moorehead-to-its-board-of-directors-301299385.html

    SOURCE Xenia Hotels & Resorts, Inc.

    Get the next $XHR alert in real time by email

    Crush Q3 2025 with the Best AI Superconnector

    Stay ahead of the competition with Standout.work - your AI-powered talent-to-startup matching platform.

    AI-Powered Inbox
    Context-aware email replies
    Strategic Decision Support
    Get Started with Standout.work

    Recent Analyst Ratings for
    $XHR
    $NATR

    CompanyDatePrice TargetRatingAnalyst
    Nature's Sunshine Products Inc.
    $NATR
    5/7/2025$19.00Buy
    DA Davidson
    Xenia Hotels & Resorts Inc.
    $XHR
    4/9/2025$10.00Buy → Hold
    Jefferies
    Xenia Hotels & Resorts Inc.
    $XHR
    9/13/2024$16.00 → $15.00Equal Weight → Overweight
    Wells Fargo
    Nature's Sunshine Products Inc.
    $NATR
    9/13/2024$18.00Buy
    Canaccord Genuity
    Xenia Hotels & Resorts Inc.
    $XHR
    3/4/2024$16.00 → $17.00Buy → Neutral
    B. Riley Securities
    Xenia Hotels & Resorts Inc.
    $XHR
    2/29/2024$14.00 → $18.00Hold → Buy
    Jefferies
    Xenia Hotels & Resorts Inc.
    $XHR
    1/10/2024Peer Perform
    Wolfe Research
    Xenia Hotels & Resorts Inc.
    $XHR
    3/30/2023$18.00 → $13.00Overweight → Equal Weight
    Wells Fargo
    More analyst ratings

    $XHR
    $NATR
    Analyst Ratings

    Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.

    View All

    DA Davidson resumed coverage on Nature's Sunshine with a new price target

    DA Davidson resumed coverage of Nature's Sunshine with a rating of Buy and set a new price target of $19.00

    5/7/25 8:37:48 AM ET
    $NATR
    Biotechnology: Pharmaceutical Preparations
    Health Care

    Xenia Hotels downgraded by Jefferies with a new price target

    Jefferies downgraded Xenia Hotels from Buy to Hold and set a new price target of $10.00

    4/9/25 8:06:14 AM ET
    $XHR
    Hotels/Resorts
    Consumer Discretionary

    Xenia Hotels upgraded by Wells Fargo with a new price target

    Wells Fargo upgraded Xenia Hotels from Equal Weight to Overweight and set a new price target of $15.00 from $16.00 previously

    9/13/24 7:48:19 AM ET
    $XHR
    Hotels/Resorts
    Consumer Discretionary

    $XHR
    $NATR
    SEC Filings

    View All

    SEC Form 10-Q filed by Xenia Hotels & Resorts Inc.

    10-Q - Xenia Hotels & Resorts, Inc. (0001616000) (Filer)

    8/1/25 4:20:53 PM ET
    $XHR
    Hotels/Resorts
    Consumer Discretionary

    Xenia Hotels & Resorts Inc. filed SEC Form 8-K: Results of Operations and Financial Condition

    8-K - Xenia Hotels & Resorts, Inc. (0001616000) (Filer)

    8/1/25 6:46:41 AM ET
    $XHR
    Hotels/Resorts
    Consumer Discretionary

    SEC Form 10-Q filed by Nature's Sunshine Products Inc.

    10-Q - NATURES SUNSHINE PRODUCTS INC (0000275053) (Filer)

    7/31/25 5:11:25 PM ET
    $NATR
    Biotechnology: Pharmaceutical Preparations
    Health Care

    $XHR
    $NATR
    Press Releases

    Fastest customizable press release news feed in the world

    View All

    Xenia Hotels & Resorts Reports Second Quarter 2025 Results

    ORLANDO, Fla., Aug. 1, 2025 /PRNewswire/ -- Xenia Hotels & Resorts, Inc. (NYSE:XHR) ("Xenia" or the "Company") today announced results for the quarter ended June 30, 2025. Second Quarter 2025 Highlights Net Income: Net income attributable to common stockholders was $55.2 million, or $0.56 per shareAdjusted EBITDAre: $79.5 million, increased 16.3% compared to the second quarter of 2024Adjusted FFO per Diluted Share: $0.57, increased 9.6% compared to the second quarter of 2024Same-Property Occupancy: 72.3%, increased 140 basis points compared to the second quarter of 2024Same-Property ADR: $270.42, increased 2.0% compared to the second quarter of 2024Same-Property RevPAR: $195.51, increased 4.

    8/1/25 6:30:00 AM ET
    $XHR
    Hotels/Resorts
    Consumer Discretionary

    Nature's Sunshine Reports Second Quarter 2025 Results

    LEHI, Utah, July 31, 2025 (GLOBE NEWSWIRE) -- Nature's Sunshine Products, Inc. (NASDAQ:NATR) ("Nature's Sunshine"), a leading manufacturer of high-quality herbal and nutritional supplements, reported financial results for the second quarter ended June 30, 2025. Second Quarter 2025 Financial Summary vs. Same Year-Ago Quarter Net sales were up 4% to $114.8 million compared to $110.6 million (up 2% in constant currency).GAAP net income attributable to common shareholders was $5.3 million, or $0.28 per diluted common share, compared to $1.3 million, or $0.07 per diluted common share.Adjusted EBITDA was up 8% to $11.3 million compared to $10.4 million. Management Commentary "We deli

    7/31/25 4:05:00 PM ET
    $NATR
    Biotechnology: Pharmaceutical Preparations
    Health Care

    Gateway Group Announces Preliminary Sponsors and Presenting Companies for 2025 Gateway Conference

    NEWPORT BEACH, Calif., July 30, 2025 (GLOBE NEWSWIRE) -- Gateway Group ("Gateway"), a leading financial communications and digital media advisory firm, today announced the initial sponsors and presenting companies confirmed for its annual Gateway Conference taking place at the Four Seasons Hotel in San Francisco on September 3rd and 4th. The conference is expected to host more than 300 institutional investors and analysts for two days of company presentations and curated one-on-one meetings with executives from high-growth public and private companies across the tech, AI, cleantech, consumer, financial services, and industrials sectors. "We appreciate the strong support from our sponsors

    7/30/25 8:30:00 AM ET
    $ACNT
    $AIRG
    $AKA
    Steel/Iron Ore
    Industrials
    Radio And Television Broadcasting And Communications Equipment
    Technology

    $XHR
    $NATR
    Financials

    Live finance-specific insights

    View All

    $XHR
    $NATR
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    View All

    $XHR
    $NATR
    Leadership Updates

    Live Leadership Updates

    View All

    Xenia Hotels & Resorts Reports Second Quarter 2025 Results

    ORLANDO, Fla., Aug. 1, 2025 /PRNewswire/ -- Xenia Hotels & Resorts, Inc. (NYSE:XHR) ("Xenia" or the "Company") today announced results for the quarter ended June 30, 2025. Second Quarter 2025 Highlights Net Income: Net income attributable to common stockholders was $55.2 million, or $0.56 per shareAdjusted EBITDAre: $79.5 million, increased 16.3% compared to the second quarter of 2024Adjusted FFO per Diluted Share: $0.57, increased 9.6% compared to the second quarter of 2024Same-Property Occupancy: 72.3%, increased 140 basis points compared to the second quarter of 2024Same-Property ADR: $270.42, increased 2.0% compared to the second quarter of 2024Same-Property RevPAR: $195.51, increased 4.

    8/1/25 6:30:00 AM ET
    $XHR
    Hotels/Resorts
    Consumer Discretionary

    Nature's Sunshine Reports Second Quarter 2025 Results

    LEHI, Utah, July 31, 2025 (GLOBE NEWSWIRE) -- Nature's Sunshine Products, Inc. (NASDAQ:NATR) ("Nature's Sunshine"), a leading manufacturer of high-quality herbal and nutritional supplements, reported financial results for the second quarter ended June 30, 2025. Second Quarter 2025 Financial Summary vs. Same Year-Ago Quarter Net sales were up 4% to $114.8 million compared to $110.6 million (up 2% in constant currency).GAAP net income attributable to common shareholders was $5.3 million, or $0.28 per diluted common share, compared to $1.3 million, or $0.07 per diluted common share.Adjusted EBITDA was up 8% to $11.3 million compared to $10.4 million. Management Commentary "We deli

    7/31/25 4:05:00 PM ET
    $NATR
    Biotechnology: Pharmaceutical Preparations
    Health Care

    Nature's Sunshine Sets Second Quarter 2025 Conference Call for Thursday, July 31, 2025, at 5:00 p.m. ET

    LEHI, Utah, July 17, 2025 (GLOBE NEWSWIRE) -- Nature's Sunshine Products, Inc. (NASDAQ:NATR) (Nature's Sunshine), a leading manufacturer of high-quality herbal and nutritional supplements, will conduct a conference call on Thursday, July 31, 2025, at 5:00 p.m. Eastern time (3:00 p.m. Mountain time) to discuss its financial results for the second quarter ended June 30, 2025. The company will report its financial results in a press release prior to the conference call. Nature's Sunshine CEO Terrence Moorehead and CFO Shane Jones will host the conference call, followed by a question and answer period. Date: Thursday, July 31, 2025Time: 5:00 p.m. Eastern time (3:00 p.m. Mountain time)Toll-fr

    7/17/25 4:05:00 PM ET
    $NATR
    Biotechnology: Pharmaceutical Preparations
    Health Care

    SVP, Chief Accounting Officer Lanoy Jonathan David sold $82,550 worth of shares (5,000 units at $16.51), decreasing direct ownership by 9% to 50,051 units (SEC Form 4)

    4 - NATURES SUNSHINE PRODUCTS INC (0000275053) (Issuer)

    8/15/25 12:45:08 PM ET
    $NATR
    Biotechnology: Pharmaceutical Preparations
    Health Care

    EVP, General Counsel Brower Nathan G sold $165,334 worth of shares (9,996 units at $16.54), decreasing direct ownership by 17% to 48,277 units (SEC Form 4)

    4 - NATURES SUNSHINE PRODUCTS INC (0000275053) (Issuer)

    8/15/25 12:12:35 PM ET
    $NATR
    Biotechnology: Pharmaceutical Preparations
    Health Care

    New insider Prescott Group Capital Management, L.L.C. claimed ownership of 1,783,097 shares (SEC Form 3)

    3 - NATURES SUNSHINE PRODUCTS INC (0000275053) (Issuer)

    8/11/25 12:51:44 PM ET
    $NATR
    Biotechnology: Pharmaceutical Preparations
    Health Care

    Nature's Sunshine Announces Leadership Transition Plan

    Board Initiates CEO Search Process Terrence Moorehead to Step Down as President and CEO, Once Successor Appointed Company Reaffirms Full Year 2025 Outlook LEHI, Utah, June 02, 2025 (GLOBE NEWSWIRE) -- Nature's Sunshine Products, Inc. (NASDAQ:NATR) ("Nature's Sunshine") (the "Company"), a leading manufacturer of high-quality herbal and nutritional supplements, today announced that Terrence Moorehead has notified the Company's Board of Directors (the "Board") of his decision to step down as President and Chief Executive Officer, effective upon the appointment of a successor. At that time, Mr. Moorehead will also resign as a member of the Board of Directors. The Nature's Sunshine Board ha

    6/2/25 9:00:00 AM ET
    $NATR
    Biotechnology: Pharmaceutical Preparations
    Health Care

    Nature's Sunshine Appoints Heidi Wissmiller as Chairman of the Board

    LEHI, Utah, May 05, 2025 (GLOBE NEWSWIRE) -- Nature's Sunshine Products, Inc. (NASDAQ:NATR), a leading natural health and wellness company of high-quality herbal and nutritional products, today announced the appointment of Heidi Wissmiller as Chairman of the Board of Directors, effective April 30, 2025. She succeeds Richard D. Moss, who has retired after serving as a Director since 2018 and Chairman since 2022. Ms. Wissmiller has served on the Board of Nature's Sunshine since 2020. Over the course of her tenure, she has chaired the Governance and Risk Management Committees. As Chief Growth Officer at Rodan + Fields ("R+F"), the leading skincare brand in North America, Ms. Wissmiller led

    5/5/25 8:00:00 AM ET
    $NATR
    Biotechnology: Pharmaceutical Preparations
    Health Care

    Nature's Sunshine Appoints Katie A. May to Board of Directors

    LEHI, Utah, Feb. 05, 2025 (GLOBE NEWSWIRE) -- Nature's Sunshine Products, Inc. (Nature's Sunshine) (NASDAQ:NATR), a leading manufacturer of high-quality herbal and nutritional supplements, today announced the appointment of Ms. Katie A. May to its board of directors effective January 30, 2025. Nature's Sunshine's board will now consist of ten directors with nine serving as independent directors. "Katie brings significant experience scaling and leading high-growth B2C, ecommerce and logistics companies," said Richard D. Moss, Chairman of the Board of Nature's Sunshine. "Her deep understanding of the full ecommerce lifecycle will strengthen and enhance our digital capabilities and drive s

    2/5/25 4:05:00 PM ET
    $NATR
    $PBI
    $STMP
    Biotechnology: Pharmaceutical Preparations
    Health Care
    Office Equipment/Supplies/Services
    Miscellaneous

    $XHR
    $NATR
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    View All

    SEC Form SC 13G/A filed by Xenia Hotels & Resorts Inc. (Amendment)

    SC 13G/A - Xenia Hotels & Resorts, Inc. (0001616000) (Subject)

    2/13/24 5:17:34 PM ET
    $XHR
    Hotels/Resorts
    Consumer Discretionary

    SEC Form SC 13G/A filed by Nature's Sunshine Products Inc. (Amendment)

    SC 13G/A - NATURES SUNSHINE PRODUCTS INC (0000275053) (Subject)

    2/12/24 10:37:49 AM ET
    $NATR
    Biotechnology: Pharmaceutical Preparations
    Health Care

    SEC Form SC 13G/A filed by Xenia Hotels & Resorts Inc. (Amendment)

    SC 13G/A - Xenia Hotels & Resorts, Inc. (0001616000) (Subject)

    2/9/24 8:40:49 AM ET
    $XHR
    Hotels/Resorts
    Consumer Discretionary